Statistics for Coherus Biosciences (id:6511 CHRS)

Valuation metrics

Market cap

94.88M

Enterprise value

261.91M

Trailing P/E (ttm)

-0.43

Forward P/E

-3.05

PEG ratio

-3.05

Price/Sales (ttm)

0.31

Price/Book (mrq)

-1.43

Enterprise Value/Revenue

0.86

Enterprise Value/EBITDA

-2.24

Overview

Shares outstanding

115.21M

Float

103.30M

Shares short

29.85M

% Held by insiders

0.01%

% Held by institutions

0.73%

Average volume (10 days)

3.36M

Average volume (90 days)

Price summary

52-Week low

0.66

52-Week high

3.70

52-Week change

-88.99%

Beta

0.69

50-Day moving average

0.99

200-Day moving average

1.71

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-0.15%

Operating margin

-9.02%

Operational effectiveness

Return on assets

-14.03%

Return on equity

122.99%

Income statement

Revenue (ttm)

2.68

Revenue per share (ttm)

2.68

Quarterly revenue growth (yoy)

Gross profit (ttm)

98.25M

EBITDA

-116,920,000.00

Net income to common (ttm)

-450,000.00

Diluted EPS (ttm)

-0.09

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

97.69M

Total cash per share (mrq)

0.85

Total debt (mrq)

269.88M

Total Debt/Equity (mrq)

-3.07

Current ratio (mrq)

124.90%

Book value per share (mrq)

-0.76

Cash flow

Cash flow statement

-61,985,000.00

Levered free cash flow (LFCF)

42.63M